MEGAN STINSON: Open Payments
NPI 1366203630 · NASHVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,281 in 73 payments from 14 companies in 2025. Trend: 2023 $15 · 2024 $1,503 · 2025 $2,281
Food & beverage: $2,281
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 11 | $686 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 12 | $454 |
| Vanda Pharmaceuticals Inc. | 7 | $268 |
| Lundbeck LLC | 5 | $138 |
| Neurocrine BioSciences, Inc. | 6 | $136 |
| Corium, LLC | 5 | $118 |
| Teva Pharmaceuticals USA, Inc. | 7 | $118 |
| Collegium Pharmaceutical, Inc. | 4 | $73 |
| Noven Therapeutics, LLC | 4 | $73 |
| ABBVIE INC. | 4 | $70 |
Products named: Auvelity, CAPLYTA, REXULTI, FANAPT, INGREZZA, Azstarys, AUSTEDO XR, HETLIOZ.
Industry payments across TN — which companies pay providers there.
